Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fallopian Tubes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05200260
What this trial is testing

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 220
Testing effectiveness (Phase 2)UnknownNCT01570582
What this trial is testing

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
Korean Gynecologic Oncology Group 314
Testing effectiveness (Phase 2)WithdrawnNCT06393751
What this trial is testing

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Who this might be right for
Platinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more
National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT06838429
What this trial is testing

PARPi and Ovarian Cancer Survival

Who this might be right for
Epithelial Ovarian Cancer, Fallopian Tube or PeritoneumPARP Inhibitor
Shanghai Gynecologic Oncology Group 6,000
Early research (Phase 1)Ended earlyNCT01312376
What this trial is testing

Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer

Who this might be right for
Ovarian CarcinomaFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Study completedNCT01905163
What this trial is testing

Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cavity Cancer
Centre Jean Perrin 47
Testing effectiveness (Phase 2)Study completedNCT03188432
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Stage IIIC Fallopian Tube CancerStage IIIC Ovarian CancerStage IIIC Primary Peritoneal Cancer+3 more
Wake Forest University Health Sciences 50
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT02788708
What this trial is testing

Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer

Who this might be right for
Fallopian Tube CarcinomaRecurrent Ovarian CancerPrimary Peritoneal Carcinoma+1 more
Floor Backes 26
Testing effectiveness (Phase 2)Study completedNCT03287674
What this trial is testing

TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer

Who this might be right for
Metastatic Ovarian Cancer
Inge Marie Svane 7
Early research (Phase 1)Study completedNCT02751918
What this trial is testing

Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer

Who this might be right for
Ovarian Neoplasms
Bayer 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT05406674
What this trial is testing

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer

Who this might be right for
FIGO Stage III Ovarian CancerPeritoneal CancerFallopian Tube Carcinoma
The Netherlands Cancer Institute 40
Testing effectiveness (Phase 2)Ended earlyNCT02364713
What this trial is testing

MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CarcinosarcomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+24 more
Mayo Clinic 17
Early research (Phase 1)Study completedNCT02483104
What this trial is testing

Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer

Who this might be right for
Ovarian Cancer
AbbVie 9
Large-scale testing (Phase 3)UnknownNCT00954174
What this trial is testing

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Mixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube Carcinoma+39 more
GOG Foundation 637
Testing effectiveness (Phase 2)Study completedNCT00096239
What this trial is testing

CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00504257
What this trial is testing

Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma

Who this might be right for
Fallopian Tube CancerOvarian CancerMalignant Tumor of Peritoneum
H. Lee Moffitt Cancer Center and Research Institute 45
Testing effectiveness (Phase 2)Looking for participantsNCT05417594
What this trial is testing

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 695
Testing effectiveness (Phase 2)Study completedNCT02354586
What this trial is testing

Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens

Who this might be right for
Ovarian NeoplasmsOvarian Cancer
Tesaro, Inc. 463
Testing effectiveness (Phase 2)WithdrawnNCT00634894
What this trial is testing

Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
M.D. Anderson Cancer Center
Next Page